nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—NTSR2—medulla oblongata—malignant glioma	0.107	0.198	CbGeAlD
Levocabastine—NTSR2—midbrain—malignant glioma	0.0976	0.181	CbGeAlD
Levocabastine—NTSR2—spinal cord—malignant glioma	0.0953	0.177	CbGeAlD
Levocabastine—NTSR2—central nervous system—malignant glioma	0.0773	0.143	CbGeAlD
Levocabastine—NTSR2—cerebellum—malignant glioma	0.0755	0.14	CbGeAlD
Levocabastine—NTSR2—brain—malignant glioma	0.0614	0.114	CbGeAlD
Levocabastine—HRH1—telencephalon—malignant glioma	0.0123	0.0228	CbGeAlD
Levocabastine—HRH1—central nervous system—malignant glioma	0.00699	0.013	CbGeAlD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00561	0.0122	CbGpPWpGaD
Levocabastine—HRH1—brain—malignant glioma	0.00555	0.0103	CbGeAlD
Levocabastine—NTSR2—G alpha (q) signalling events—F2—malignant glioma	0.00548	0.0119	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—F2—malignant glioma	0.00541	0.0117	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCR3—malignant glioma	0.00514	0.0111	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.0049	0.0106	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—BDKRB2—malignant glioma	0.0047	0.0102	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00461	0.00999	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LATS1—malignant glioma	0.00448	0.0097	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—KNG1—malignant glioma	0.00427	0.00927	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CCR4—malignant glioma	0.00391	0.00847	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00381	0.00826	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.00368	0.00798	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00363	0.00787	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCR4—malignant glioma	0.00355	0.00769	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MDK—malignant glioma	0.00302	0.00655	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCR3—malignant glioma	0.0029	0.00629	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—DTX1—malignant glioma	0.00288	0.00625	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—F2—malignant glioma	0.00276	0.00599	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—BDKRB2—malignant glioma	0.00266	0.00576	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCR3—malignant glioma	0.00264	0.00572	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—BIRC5—malignant glioma	0.00263	0.00571	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00256	0.00554	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00252	0.00547	CbGpPWpGaD
Levocabastine—NTSR2—G alpha (q) signalling events—PIK3CA—malignant glioma	0.00245	0.00531	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—KNG1—malignant glioma	0.00242	0.00524	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—BDKRB2—malignant glioma	0.00241	0.00523	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.00238	0.00517	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SUFU—malignant glioma	0.00229	0.00497	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HEY2—malignant glioma	0.00226	0.00491	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—BAD—malignant glioma	0.00222	0.00481	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—GFAP—malignant glioma	0.00221	0.00479	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—KNG1—malignant glioma	0.00219	0.00476	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.00219	0.00475	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SPHK1—malignant glioma	0.00214	0.00464	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PTPN11—malignant glioma	0.00211	0.00458	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HEY1—malignant glioma	0.0021	0.00454	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCR4—malignant glioma	0.0021	0.00454	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HIST1H3B—malignant glioma	0.00204	0.00441	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCL8—malignant glioma	0.00195	0.00422	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—MMP3—malignant glioma	0.00194	0.00421	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PIK3CD—malignant glioma	0.00189	0.00409	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—JAG2—malignant glioma	0.00186	0.00403	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00161	0.00348	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—H3F3A—malignant glioma	0.00157	0.00341	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—F2—malignant glioma	0.00156	0.00339	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCR3—malignant glioma	0.00156	0.00338	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—YWHAE—malignant glioma	0.00152	0.00328	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NTRK2—malignant glioma	0.00152	0.00328	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FLT1—malignant glioma	0.00151	0.00327	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—DUSP6—malignant glioma	0.0015	0.00326	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CG—malignant glioma	0.00149	0.00324	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—JAG1—malignant glioma	0.00148	0.00321	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOTCH3—malignant glioma	0.00148	0.0032	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FBXW7—malignant glioma	0.00145	0.00315	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—BDKRB2—malignant glioma	0.00142	0.00309	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—F2—malignant glioma	0.00142	0.00307	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—BDKRB2—malignant glioma	0.00141	0.00306	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00138	0.00299	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AKT2—malignant glioma	0.00137	0.00296	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CG—malignant glioma	0.00136	0.00294	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PTPN11—malignant glioma	0.00133	0.00289	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOTCH2—malignant glioma	0.00132	0.00287	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CD—malignant glioma	0.00131	0.00285	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KNG1—malignant glioma	0.0013	0.00281	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—KNG1—malignant glioma	0.00129	0.00279	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—STAT3—malignant glioma	0.00127	0.00276	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00126	0.00274	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AKT2—malignant glioma	0.00124	0.00269	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NTRK1—malignant glioma	0.00124	0.00268	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00119	0.00259	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CD—malignant glioma	0.00119	0.00259	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00115	0.00249	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP3—malignant glioma	0.00115	0.00249	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CB—malignant glioma	0.00114	0.00248	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CDKN2B—malignant glioma	0.00114	0.00247	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTK2—malignant glioma	0.00111	0.0024	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL8—malignant glioma	0.0011	0.00239	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00109	0.00237	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HES1—malignant glioma	0.00109	0.00235	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NCOR1—malignant glioma	0.00108	0.00234	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—RAF1—malignant glioma	0.00106	0.00231	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—IL2—malignant glioma	0.00105	0.00228	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCR4—malignant glioma	0.00105	0.00227	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CB—malignant glioma	0.00104	0.00225	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PDGFRA—malignant glioma	0.00103	0.00224	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00102	0.00222	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00102	0.00221	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SPP1—malignant glioma	0.001	0.00218	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PIK3CA—malignant glioma	0.001	0.00218	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL8—malignant glioma	0.000999	0.00217	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL2—malignant glioma	0.000955	0.00207	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TERT—malignant glioma	0.000951	0.00206	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000936	0.00203	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PDGFB—malignant glioma	0.000929	0.00201	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGFR1—malignant glioma	0.000924	0.002	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HIF1A—malignant glioma	0.00091	0.00197	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LATS2—malignant glioma	0.000896	0.00194	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CAV1—malignant glioma	0.00088	0.00191	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KDR—malignant glioma	0.00087	0.00189	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000851	0.00185	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FN1—malignant glioma	0.000838	0.00182	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—F2—malignant glioma	0.000838	0.00182	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—F2—malignant glioma	0.000831	0.0018	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—BAD—malignant glioma	0.000828	0.00179	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—AKT1—malignant glioma	0.00082	0.00178	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOTCH1—malignant glioma	0.00082	0.00178	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CD80—malignant glioma	0.000803	0.00174	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CG—malignant glioma	0.000802	0.00174	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APC—malignant glioma	0.000802	0.00174	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGF—malignant glioma	0.000792	0.00172	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTPN11—malignant glioma	0.000788	0.00171	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCR3—malignant glioma	0.000779	0.00169	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—BRAF—malignant glioma	0.000753	0.00163	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.000743	0.00161	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AKT2—malignant glioma	0.000733	0.00159	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—EGFR—malignant glioma	0.00073	0.00158	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—BDKRB2—malignant glioma	0.000713	0.00155	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CD—malignant glioma	0.000705	0.00153	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000699	0.00152	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000698	0.00151	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—KRAS—malignant glioma	0.00069	0.0015	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LATS1—malignant glioma	0.000679	0.00147	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGF2—malignant glioma	0.000675	0.00146	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—KNG1—malignant glioma	0.000648	0.00141	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CA—malignant glioma	0.000634	0.00137	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MDM2—malignant glioma	0.000631	0.00137	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—RAF1—malignant glioma	0.000629	0.00136	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ERBB2—malignant glioma	0.000622	0.00135	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CB—malignant glioma	0.000614	0.00133	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR4—malignant glioma	0.000593	0.00128	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL8—malignant glioma	0.00059	0.00128	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AKT1—malignant glioma	0.00057	0.00124	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CASP3—malignant glioma	0.000565	0.00122	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL2—malignant glioma	0.000564	0.00122	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000558	0.00121	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00055	0.00119	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR4—malignant glioma	0.000538	0.00117	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—malignant glioma	0.000534	0.00116	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTEN—malignant glioma	0.000531	0.00115	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AKT1—malignant glioma	0.000518	0.00112	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFA—malignant glioma	0.000479	0.00104	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STAT3—malignant glioma	0.000475	0.00103	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MDK—malignant glioma	0.000459	0.000994	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MYC—malignant glioma	0.000441	0.000956	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCR3—malignant glioma	0.00044	0.000955	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DTX1—malignant glioma	0.000437	0.000948	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGFR—malignant glioma	0.000431	0.000935	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—F2—malignant glioma	0.000419	0.000909	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KRAS—malignant glioma	0.000408	0.000884	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000403	0.000873	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCR3—malignant glioma	0.0004	0.000867	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000388	0.000841	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000383	0.00083	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CA—malignant glioma	0.000374	0.000812	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000371	0.000805	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—KNG1—malignant glioma	0.000366	0.000794	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—BDKRB2—malignant glioma	0.000366	0.000793	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TP53—malignant glioma	0.000362	0.000785	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000362	0.000784	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SUFU—malignant glioma	0.000348	0.000753	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HEY2—malignant glioma	0.000343	0.000744	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GFAP—malignant glioma	0.000335	0.000727	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—KNG1—malignant glioma	0.000333	0.000721	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000332	0.00072	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SPHK1—malignant glioma	0.000324	0.000703	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HEY1—malignant glioma	0.000318	0.000689	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR4—malignant glioma	0.000318	0.000689	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HIST1H3B—malignant glioma	0.000309	0.000669	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AKT1—malignant glioma	0.000306	0.000663	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL8—malignant glioma	0.000295	0.00064	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MMP3—malignant glioma	0.000295	0.000639	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JAG2—malignant glioma	0.000282	0.000611	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—H3F3A—malignant glioma	0.000239	0.000517	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—F2—malignant glioma	0.000237	0.000513	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCR3—malignant glioma	0.000236	0.000512	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—YWHAE—malignant glioma	0.00023	0.000498	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NTRK2—malignant glioma	0.00023	0.000498	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FLT1—malignant glioma	0.000229	0.000496	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DUSP6—malignant glioma	0.000228	0.000494	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000227	0.000491	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JAG1—malignant glioma	0.000225	0.000488	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOTCH3—malignant glioma	0.000224	0.000486	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FBXW7—malignant glioma	0.00022	0.000478	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BDKRB2—malignant glioma	0.000216	0.000468	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—F2—malignant glioma	0.000215	0.000466	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AKT2—malignant glioma	0.000207	0.00045	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CG—malignant glioma	0.000206	0.000446	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTPN11—malignant glioma	0.000202	0.000438	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOTCH2—malignant glioma	0.000201	0.000435	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000199	0.000432	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KNG1—malignant glioma	0.000197	0.000426	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AKT2—malignant glioma	0.000188	0.000408	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NTRK1—malignant glioma	0.000187	0.000406	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	0.000181	0.000392	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP3—malignant glioma	0.000174	0.000378	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000174	0.000377	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CDKN2B—malignant glioma	0.000173	0.000374	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTK2—malignant glioma	0.000168	0.000363	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	0.000167	0.000362	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HES1—malignant glioma	0.000165	0.000357	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NCOR1—malignant glioma	0.000164	0.000355	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—RAF1—malignant glioma	0.000162	0.00035	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL2—malignant glioma	0.000159	0.000346	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	0.000158	0.000342	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	0.000157	0.00034	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SPP1—malignant glioma	0.000152	0.00033	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	0.000152	0.000329	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL2—malignant glioma	0.000145	0.000314	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TERT—malignant glioma	0.000144	0.000313	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PDGFB—malignant glioma	0.000141	0.000305	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGFR1—malignant glioma	0.00014	0.000304	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HIF1A—malignant glioma	0.000138	0.000299	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CAV1—malignant glioma	0.000133	0.000289	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KDR—malignant glioma	0.000132	0.000286	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FN1—malignant glioma	0.000127	0.000275	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—F2—malignant glioma	0.000127	0.000275	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BAD—malignant glioma	0.000126	0.000272	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	0.000124	0.00027	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CD80—malignant glioma	0.000122	0.000264	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APC—malignant glioma	0.000122	0.000264	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	0.000122	0.000264	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGF—malignant glioma	0.00012	0.000261	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTPN11—malignant glioma	0.000119	0.000259	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BRAF—malignant glioma	0.000114	0.000248	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKT2—malignant glioma	0.000111	0.000241	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EGFR—malignant glioma	0.000111	0.00024	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	0.000107	0.000232	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000106	0.00023	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—KRAS—malignant glioma	0.000105	0.000227	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGF2—malignant glioma	0.000102	0.000222	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	9.61e-05	0.000208	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MDM2—malignant glioma	9.58e-05	0.000208	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RAF1—malignant glioma	9.54e-05	0.000207	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ERBB2—malignant glioma	9.44e-05	0.000205	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	9.32e-05	0.000202	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL8—malignant glioma	8.95e-05	0.000194	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	8.65e-05	0.000188	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CASP3—malignant glioma	8.57e-05	0.000186	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL2—malignant glioma	8.56e-05	0.000186	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—malignant glioma	8.1e-05	0.000176	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTEN—malignant glioma	8.05e-05	0.000175	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AKT1—malignant glioma	7.85e-05	0.00017	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFA—malignant glioma	7.27e-05	0.000158	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STAT3—malignant glioma	7.2e-05	0.000156	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MYC—malignant glioma	6.69e-05	0.000145	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGFR—malignant glioma	6.54e-05	0.000142	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KRAS—malignant glioma	6.18e-05	0.000134	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	5.68e-05	0.000123	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TP53—malignant glioma	5.49e-05	0.000119	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKT1—malignant glioma	4.64e-05	0.000101	CbGpPWpGaD
